Request for Covid-19 Impact Assessment of this Report
The United States Montelukast Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Montelukast Drug market, reaching US$ million by the year 2028. As for the Europe Montelukast Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Montelukast Drug players cover Merck & Co., Teva, Mylan, and Glenmark Pharmaceuticals, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Oral Granules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Drug Store
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck & Co.
Teva
Mylan
Glenmark Pharmaceuticals
Hikma Group
Sandoz
Torrent Pharmaceuticals
Lannett Company
Apotex
Dr. Reddys Laboratories
Aurobindo Pharma
Accord Healthcare
Hetero
Unimark
Ajanta Pharma
MACLEODS
Jubilant Pharma
Unichem Laboratories
Amneal Pharmaceuticals
Shanghai Anbison Lab
Perrigo
Cipla
CSPC Ouyi Pharmaceutical
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Montelukast Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Montelukast Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Montelukast Drug by Country/Region, 2017, 2022 & 2028
2.2 Montelukast Drug Segment by Type
2.2.1 Tablets
2.2.2 Oral Granules
2.3 Montelukast Drug Sales by Type
2.3.1 Global Montelukast Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Montelukast Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Montelukast Drug Sale Price by Type (2017-2022)
2.4 Montelukast Drug Segment by Application
2.4.1 Hospital
2.4.2 Drug Store
2.4.3 Others
2.5 Montelukast Drug Sales by Application
2.5.1 Global Montelukast Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Montelukast Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Montelukast Drug Sale Price by Application (2017-2022)
3 Global Montelukast Drug by Company
3.1 Global Montelukast Drug Breakdown Data by Company
3.1.1 Global Montelukast Drug Annual Sales by Company (2020-2022)
3.1.2 Global Montelukast Drug Sales Market Share by Company (2020-2022)
3.2 Global Montelukast Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Montelukast Drug Revenue by Company (2020-2022)
3.2.2 Global Montelukast Drug Revenue Market Share by Company (2020-2022)
3.3 Global Montelukast Drug Sale Price by Company
3.4 Key Manufacturers Montelukast Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Montelukast Drug Product Location Distribution
3.4.2 Players Montelukast Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Montelukast Drug by Geographic Region
4.1 World Historic Montelukast Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Montelukast Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Montelukast Drug Annual Revenue by Geographic Region
4.2 World Historic Montelukast Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Montelukast Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Montelukast Drug Annual Revenue by Country/Region
4.3 Americas Montelukast Drug Sales Growth
4.4 APAC Montelukast Drug Sales Growth
4.5 Europe Montelukast Drug Sales Growth
4.6 Middle East & Africa Montelukast Drug Sales Growth
5 Americas
5.1 Americas Montelukast Drug Sales by Country
5.1.1 Americas Montelukast Drug Sales by Country (2017-2022)
5.1.2 Americas Montelukast Drug Revenue by Country (2017-2022)
5.2 Americas Montelukast Drug Sales by Type
5.3 Americas Montelukast Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Montelukast Drug Sales by Region
6.1.1 APAC Montelukast Drug Sales by Region (2017-2022)
6.1.2 APAC Montelukast Drug Revenue by Region (2017-2022)
6.2 APAC Montelukast Drug Sales by Type
6.3 APAC Montelukast Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Montelukast Drug by Country
7.1.1 Europe Montelukast Drug Sales by Country (2017-2022)
7.1.2 Europe Montelukast Drug Revenue by Country (2017-2022)
7.2 Europe Montelukast Drug Sales by Type
7.3 Europe Montelukast Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Montelukast Drug by Country
8.1.1 Middle East & Africa Montelukast Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Montelukast Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Montelukast Drug Sales by Type
8.3 Middle East & Africa Montelukast Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Montelukast Drug
10.3 Manufacturing Process Analysis of Montelukast Drug
10.4 Industry Chain Structure of Montelukast Drug
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Montelukast Drug Distributors
11.3 Montelukast Drug Customer
12 World Forecast Review for Montelukast Drug by Geographic Region
12.1 Global Montelukast Drug Market Size Forecast by Region
12.1.1 Global Montelukast Drug Forecast by Region (2023-2028)
12.1.2 Global Montelukast Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Montelukast Drug Forecast by Type
12.7 Global Montelukast Drug Forecast by Application
13 Key Players Analysis
13.1 Merck & Co.
13.1.1 Merck & Co. Company Information
13.1.2 Merck & Co. Montelukast Drug Product Offered
13.1.3 Merck & Co. Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Merck & Co. Main Business Overview
13.1.5 Merck & Co. Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Montelukast Drug Product Offered
13.2.3 Teva Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Mylan
13.3.1 Mylan Company Information
13.3.2 Mylan Montelukast Drug Product Offered
13.3.3 Mylan Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Mylan Main Business Overview
13.3.5 Mylan Latest Developments
13.4 Glenmark Pharmaceuticals
13.4.1 Glenmark Pharmaceuticals Company Information
13.4.2 Glenmark Pharmaceuticals Montelukast Drug Product Offered
13.4.3 Glenmark Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Glenmark Pharmaceuticals Main Business Overview
13.4.5 Glenmark Pharmaceuticals Latest Developments
13.5 Hikma Group
13.5.1 Hikma Group Company Information
13.5.2 Hikma Group Montelukast Drug Product Offered
13.5.3 Hikma Group Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Hikma Group Main Business Overview
13.5.5 Hikma Group Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Montelukast Drug Product Offered
13.6.3 Sandoz Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Torrent Pharmaceuticals
13.7.1 Torrent Pharmaceuticals Company Information
13.7.2 Torrent Pharmaceuticals Montelukast Drug Product Offered
13.7.3 Torrent Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Torrent Pharmaceuticals Main Business Overview
13.7.5 Torrent Pharmaceuticals Latest Developments
13.8 Lannett Company
13.8.1 Lannett Company Company Information
13.8.2 Lannett Company Montelukast Drug Product Offered
13.8.3 Lannett Company Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Lannett Company Main Business Overview
13.8.5 Lannett Company Latest Developments
13.9 Apotex
13.9.1 Apotex Company Information
13.9.2 Apotex Montelukast Drug Product Offered
13.9.3 Apotex Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Apotex Main Business Overview
13.9.5 Apotex Latest Developments
13.10 Dr. Reddys Laboratories
13.10.1 Dr. Reddys Laboratories Company Information
13.10.2 Dr. Reddys Laboratories Montelukast Drug Product Offered
13.10.3 Dr. Reddys Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Dr. Reddys Laboratories Main Business Overview
13.10.5 Dr. Reddys Laboratories Latest Developments
13.11 Aurobindo Pharma
13.11.1 Aurobindo Pharma Company Information
13.11.2 Aurobindo Pharma Montelukast Drug Product Offered
13.11.3 Aurobindo Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Aurobindo Pharma Main Business Overview
13.11.5 Aurobindo Pharma Latest Developments
13.12 Accord Healthcare
13.12.1 Accord Healthcare Company Information
13.12.2 Accord Healthcare Montelukast Drug Product Offered
13.12.3 Accord Healthcare Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Accord Healthcare Main Business Overview
13.12.5 Accord Healthcare Latest Developments
13.13 Hetero
13.13.1 Hetero Company Information
13.13.2 Hetero Montelukast Drug Product Offered
13.13.3 Hetero Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Hetero Main Business Overview
13.13.5 Hetero Latest Developments
13.14 Unimark
13.14.1 Unimark Company Information
13.14.2 Unimark Montelukast Drug Product Offered
13.14.3 Unimark Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Unimark Main Business Overview
13.14.5 Unimark Latest Developments
13.15 Ajanta Pharma
13.15.1 Ajanta Pharma Company Information
13.15.2 Ajanta Pharma Montelukast Drug Product Offered
13.15.3 Ajanta Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Ajanta Pharma Main Business Overview
13.15.5 Ajanta Pharma Latest Developments
13.16 MACLEODS
13.16.1 MACLEODS Company Information
13.16.2 MACLEODS Montelukast Drug Product Offered
13.16.3 MACLEODS Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 MACLEODS Main Business Overview
13.16.5 MACLEODS Latest Developments
13.17 Jubilant Pharma
13.17.1 Jubilant Pharma Company Information
13.17.2 Jubilant Pharma Montelukast Drug Product Offered
13.17.3 Jubilant Pharma Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Jubilant Pharma Main Business Overview
13.17.5 Jubilant Pharma Latest Developments
13.18 Unichem Laboratories
13.18.1 Unichem Laboratories Company Information
13.18.2 Unichem Laboratories Montelukast Drug Product Offered
13.18.3 Unichem Laboratories Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Unichem Laboratories Main Business Overview
13.18.5 Unichem Laboratories Latest Developments
13.19 Amneal Pharmaceuticals
13.19.1 Amneal Pharmaceuticals Company Information
13.19.2 Amneal Pharmaceuticals Montelukast Drug Product Offered
13.19.3 Amneal Pharmaceuticals Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Amneal Pharmaceuticals Main Business Overview
13.19.5 Amneal Pharmaceuticals Latest Developments
13.20 Shanghai Anbison Lab
13.20.1 Shanghai Anbison Lab Company Information
13.20.2 Shanghai Anbison Lab Montelukast Drug Product Offered
13.20.3 Shanghai Anbison Lab Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Shanghai Anbison Lab Main Business Overview
13.20.5 Shanghai Anbison Lab Latest Developments
13.21 Perrigo
13.21.1 Perrigo Company Information
13.21.2 Perrigo Montelukast Drug Product Offered
13.21.3 Perrigo Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.21.4 Perrigo Main Business Overview
13.21.5 Perrigo Latest Developments
13.22 Cipla
13.22.1 Cipla Company Information
13.22.2 Cipla Montelukast Drug Product Offered
13.22.3 Cipla Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.22.4 Cipla Main Business Overview
13.22.5 Cipla Latest Developments
13.23 CSPC Ouyi Pharmaceutical
13.23.1 CSPC Ouyi Pharmaceutical Company Information
13.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Offered
13.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.23.4 CSPC Ouyi Pharmaceutical Main Business Overview
13.23.5 CSPC Ouyi Pharmaceutical Latest Developments
14 Research Findings and Conclusion
Table 1. Montelukast Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Montelukast Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Oral Granules
Table 5. Global Montelukast Drug Sales by Type (2017-2022) & (K Units)
Table 6. Global Montelukast Drug Sales Market Share by Type (2017-2022)
Table 7. Global Montelukast Drug Revenue by Type (2017-2022) & ($ million)
Table 8. Global Montelukast Drug Revenue Market Share by Type (2017-2022)
Table 9. Global Montelukast Drug Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global Montelukast Drug Sales by Application (2017-2022) & (K Units)
Table 11. Global Montelukast Drug Sales Market Share by Application (2017-2022)
Table 12. Global Montelukast Drug Revenue by Application (2017-2022)
Table 13. Global Montelukast Drug Revenue Market Share by Application (2017-2022)
Table 14. Global Montelukast Drug Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global Montelukast Drug Sales by Company (2020-2022) & (K Units)
Table 16. Global Montelukast Drug Sales Market Share by Company (2020-2022)
Table 17. Global Montelukast Drug Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Montelukast Drug Revenue Market Share by Company (2020-2022)
Table 19. Global Montelukast Drug Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers Montelukast Drug Producing Area Distribution and Sales Area
Table 21. Players Montelukast Drug Products Offered
Table 22. Montelukast Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Montelukast Drug Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Montelukast Drug Sales Market Share Geographic Region (2017-2022)
Table 27. Global Montelukast Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Montelukast Drug Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Montelukast Drug Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Montelukast Drug Sales Market Share by Country/Region (2017-2022)
Table 31. Global Montelukast Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Montelukast Drug Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Montelukast Drug Sales by Country (2017-2022) & (K Units)
Table 34. Americas Montelukast Drug Sales Market Share by Country (2017-2022)
Table 35. Americas Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Montelukast Drug Revenue Market Share by Country (2017-2022)
Table 37. Americas Montelukast Drug Sales by Type (2017-2022) & (K Units)
Table 38. Americas Montelukast Drug Sales Market Share by Type (2017-2022)
Table 39. Americas Montelukast Drug Sales by Application (2017-2022) & (K Units)
Table 40. Americas Montelukast Drug Sales Market Share by Application (2017-2022)
Table 41. APAC Montelukast Drug Sales by Region (2017-2022) & (K Units)
Table 42. APAC Montelukast Drug Sales Market Share by Region (2017-2022)
Table 43. APAC Montelukast Drug Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Montelukast Drug Revenue Market Share by Region (2017-2022)
Table 45. APAC Montelukast Drug Sales by Type (2017-2022) & (K Units)
Table 46. APAC Montelukast Drug Sales Market Share by Type (2017-2022)
Table 47. APAC Montelukast Drug Sales by Application (2017-2022) & (K Units)
Table 48. APAC Montelukast Drug Sales Market Share by Application (2017-2022)
Table 49. Europe Montelukast Drug Sales by Country (2017-2022) & (K Units)
Table 50. Europe Montelukast Drug Sales Market Share by Country (2017-2022)
Table 51. Europe Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Montelukast Drug Revenue Market Share by Country (2017-2022)
Table 53. Europe Montelukast Drug Sales by Type (2017-2022) & (K Units)
Table 54. Europe Montelukast Drug Sales Market Share by Type (2017-2022)
Table 55. Europe Montelukast Drug Sales by Application (2017-2022) & (K Units)
Table 56. Europe Montelukast Drug Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Montelukast Drug Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Montelukast Drug Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Montelukast Drug Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Montelukast Drug Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Montelukast Drug Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Montelukast Drug Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Montelukast Drug Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Montelukast Drug Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Montelukast Drug
Table 66. Key Market Challenges & Risks of Montelukast Drug
Table 67. Key Industry Trends of Montelukast Drug
Table 68. Montelukast Drug Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Montelukast Drug Distributors List
Table 71. Montelukast Drug Customer List
Table 72. Global Montelukast Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Montelukast Drug Sales Market Forecast by Region
Table 74. Global Montelukast Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Montelukast Drug Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Montelukast Drug Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Montelukast Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Montelukast Drug Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Montelukast Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Montelukast Drug Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Montelukast Drug Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Montelukast Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Montelukast Drug Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Montelukast Drug Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Montelukast Drug Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Montelukast Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Montelukast Drug Revenue Market Share Forecast by Application (2023-2028)
Table 92. Merck & Co. Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 93. Merck & Co. Montelukast Drug Product Offered
Table 94. Merck & Co. Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. Merck & Co. Main Business
Table 96. Merck & Co. Latest Developments
Table 97. Teva Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 98. Teva Montelukast Drug Product Offered
Table 99. Teva Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Teva Main Business
Table 101. Teva Latest Developments
Table 102. Mylan Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 103. Mylan Montelukast Drug Product Offered
Table 104. Mylan Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Mylan Main Business
Table 106. Mylan Latest Developments
Table 107. Glenmark Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 108. Glenmark Pharmaceuticals Montelukast Drug Product Offered
Table 109. Glenmark Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Glenmark Pharmaceuticals Main Business
Table 111. Glenmark Pharmaceuticals Latest Developments
Table 112. Hikma Group Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 113. Hikma Group Montelukast Drug Product Offered
Table 114. Hikma Group Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Hikma Group Main Business
Table 116. Hikma Group Latest Developments
Table 117. Sandoz Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 118. Sandoz Montelukast Drug Product Offered
Table 119. Sandoz Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Sandoz Main Business
Table 121. Sandoz Latest Developments
Table 122. Torrent Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 123. Torrent Pharmaceuticals Montelukast Drug Product Offered
Table 124. Torrent Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. Torrent Pharmaceuticals Main Business
Table 126. Torrent Pharmaceuticals Latest Developments
Table 127. Lannett Company Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 128. Lannett Company Montelukast Drug Product Offered
Table 129. Lannett Company Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Lannett Company Main Business
Table 131. Lannett Company Latest Developments
Table 132. Apotex Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 133. Apotex Montelukast Drug Product Offered
Table 134. Apotex Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Apotex Main Business
Table 136. Apotex Latest Developments
Table 137. Dr. Reddys Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 138. Dr. Reddys Laboratories Montelukast Drug Product Offered
Table 139. Dr. Reddys Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 140. Dr. Reddys Laboratories Main Business
Table 141. Dr. Reddys Laboratories Latest Developments
Table 142. Aurobindo Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 143. Aurobindo Pharma Montelukast Drug Product Offered
Table 144. Aurobindo Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 145. Aurobindo Pharma Main Business
Table 146. Aurobindo Pharma Latest Developments
Table 147. Accord Healthcare Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 148. Accord Healthcare Montelukast Drug Product Offered
Table 149. Accord Healthcare Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 150. Accord Healthcare Main Business
Table 151. Accord Healthcare Latest Developments
Table 152. Hetero Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 153. Hetero Montelukast Drug Product Offered
Table 154. Hetero Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 155. Hetero Main Business
Table 156. Hetero Latest Developments
Table 157. Unimark Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 158. Unimark Montelukast Drug Product Offered
Table 159. Unimark Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 160. Unimark Main Business
Table 161. Unimark Latest Developments
Table 162. Ajanta Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 163. Ajanta Pharma Montelukast Drug Product Offered
Table 164. Ajanta Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 165. Ajanta Pharma Main Business
Table 166. Ajanta Pharma Latest Developments
Table 167. MACLEODS Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 168. MACLEODS Montelukast Drug Product Offered
Table 169. MACLEODS Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 170. MACLEODS Main Business
Table 171. MACLEODS Latest Developments
Table 172. Jubilant Pharma Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 173. Jubilant Pharma Montelukast Drug Product Offered
Table 174. Jubilant Pharma Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 175. Jubilant Pharma Main Business
Table 176. Jubilant Pharma Latest Developments
Table 177. Unichem Laboratories Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 178. Unichem Laboratories Montelukast Drug Product Offered
Table 179. Unichem Laboratories Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 180. Unichem Laboratories Main Business
Table 181. Unichem Laboratories Latest Developments
Table 182. Amneal Pharmaceuticals Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 183. Amneal Pharmaceuticals Montelukast Drug Product Offered
Table 184. Amneal Pharmaceuticals Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 185. Amneal Pharmaceuticals Main Business
Table 186. Amneal Pharmaceuticals Latest Developments
Table 187. Shanghai Anbison Lab Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 188. Shanghai Anbison Lab Montelukast Drug Product Offered
Table 189. Shanghai Anbison Lab Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 190. Shanghai Anbison Lab Main Business
Table 191. Shanghai Anbison Lab Latest Developments
Table 192. Perrigo Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 193. Perrigo Montelukast Drug Product Offered
Table 194. Perrigo Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 195. Perrigo Main Business
Table 196. Perrigo Latest Developments
Table 197. Cipla Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 198. Cipla Montelukast Drug Product Offered
Table 199. Cipla Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 200. Cipla Main Business
Table 201. Cipla Latest Developments
Table 202. CSPC Ouyi Pharmaceutical Basic Information, Montelukast Drug Manufacturing Base, Sales Area and Its Competitors
Table 203. CSPC Ouyi Pharmaceutical Montelukast Drug Product Offered
Table 204. CSPC Ouyi Pharmaceutical Montelukast Drug Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 205. CSPC Ouyi Pharmaceutical Main Business
Table 206. CSPC Ouyi Pharmaceutical Latest Developments
List of Figures
Figure 1. Picture of Montelukast Drug
Figure 2. Montelukast Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Montelukast Drug Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Montelukast Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Montelukast Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Oral Granules
Figure 11. Global Montelukast Drug Sales Market Share by Type in 2021
Figure 12. Global Montelukast Drug Revenue Market Share by Type (2017-2022)
Figure 13. Montelukast Drug Consumed in Hospital
Figure 14. Global Montelukast Drug Market: Hospital (2017-2022) & (K Units)
Figure 15. Montelukast Drug Consumed in Drug Store
Figure 16. Global Montelukast Drug Market: Drug Store (2017-2022) & (K Units)
Figure 17. Montelukast Drug Consumed in Others
Figure 18. Global Montelukast Drug Market: Others (2017-2022) & (K Units)
Figure 19. Global Montelukast Drug Sales Market Share by Application (2017-2022)
Figure 20. Global Montelukast Drug Revenue Market Share by Application in 2021
Figure 21. Montelukast Drug Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Montelukast Drug Revenue Market Share by Company in 2021
Figure 23. Global Montelukast Drug Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Montelukast Drug Revenue Market Share by Geographic Region in 2021
Figure 25. Global Montelukast Drug Sales Market Share by Region (2017-2022)
Figure 26. Global Montelukast Drug Revenue Market Share by Country/Region in 2021
Figure 27. Americas Montelukast Drug Sales 2017-2022 (K Units)
Figure 28. Americas Montelukast Drug Revenue 2017-2022 ($ Millions)
Figure 29. APAC Montelukast Drug Sales 2017-2022 (K Units)
Figure 30. APAC Montelukast Drug Revenue 2017-2022 ($ Millions)
Figure 31. Europe Montelukast Drug Sales 2017-2022 (K Units)
Figure 32. Europe Montelukast Drug Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Montelukast Drug Sales 2017-2022 (K Units)
Figure 34. Middle East & Africa Montelukast Drug Revenue 2017-2022 ($ Millions)
Figure 35. Americas Montelukast Drug Sales Market Share by Country in 2021
Figure 36. Americas Montelukast Drug Revenue Market Share by Country in 2021
Figure 37. United States Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Montelukast Drug Sales Market Share by Region in 2021
Figure 42. APAC Montelukast Drug Revenue Market Share by Regions in 2021
Figure 43. China Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Montelukast Drug Sales Market Share by Country in 2021
Figure 50. Europe Montelukast Drug Revenue Market Share by Country in 2021
Figure 51. Germany Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Montelukast Drug Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Montelukast Drug Revenue Market Share by Country in 2021
Figure 58. Egypt Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Montelukast Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Montelukast Drug in 2021
Figure 64. Manufacturing Process Analysis of Montelukast Drug
Figure 65. Industry Chain Structure of Montelukast Drug
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...